Big deals carry big risks, and Hologic (HOLX)
does not have a great record with big deals. Couple that with a
difficult hospital spending environment and I can understand why Hologic
shares trade at a discount to fair value. That said, investors who want
to buy into women's health and diagnostics could certainly do worse
than to consider this name.
Please continue here:
Hologic Seems A Little Underrated
No comments:
Post a Comment